WO2009072578A1 - Bone resorption inhibitor - Google Patents

Bone resorption inhibitor Download PDF

Info

Publication number
WO2009072578A1
WO2009072578A1 PCT/JP2008/072087 JP2008072087W WO2009072578A1 WO 2009072578 A1 WO2009072578 A1 WO 2009072578A1 JP 2008072087 W JP2008072087 W JP 2008072087W WO 2009072578 A1 WO2009072578 A1 WO 2009072578A1
Authority
WO
WIPO (PCT)
Prior art keywords
bone resorption
resorption inhibitor
acid
beverage
food
Prior art date
Application number
PCT/JP2008/072087
Other languages
French (fr)
Japanese (ja)
Inventor
Jun Fuchimoto
Yukio Okada
Original Assignee
Sapporo Breweries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sapporo Breweries Limited filed Critical Sapporo Breweries Limited
Priority to JP2009544721A priority Critical patent/JP5214632B2/en
Publication of WO2009072578A1 publication Critical patent/WO2009072578A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Disclosed is a novel bone resorption inhibitor comprising at least one component selected from the group consisting of a tetrahydroisoalpha acid, a rhoisoalpha acid and a hexahydroisoalpha acid as an active ingredient. Also disclosed is a medicinal preparation, an additive for a food or beverage, a food, a beverage, a feed additive, a feed or the like comprising the bone resorption inhibitor.
PCT/JP2008/072087 2007-12-04 2008-12-04 Bone resorption inhibitor WO2009072578A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009544721A JP5214632B2 (en) 2007-12-04 2008-12-04 Bone resorption inhibitor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007313894 2007-12-04
JP2007-313894 2007-12-04

Publications (1)

Publication Number Publication Date
WO2009072578A1 true WO2009072578A1 (en) 2009-06-11

Family

ID=40717755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/072087 WO2009072578A1 (en) 2007-12-04 2008-12-04 Bone resorption inhibitor

Country Status (2)

Country Link
JP (1) JP5214632B2 (en)
WO (1) WO2009072578A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07330594A (en) * 1994-04-12 1995-12-19 Hoechst Japan Ltd Therapeutic agent for osteoporosis
WO2003068205A1 (en) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2659032A1 (en) * 2006-07-21 2008-01-24 Ramot At Tel Aviv University Ltd. Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07330594A (en) * 1994-04-12 1995-12-19 Hoechst Japan Ltd Therapeutic agent for osteoporosis
WO2003068205A1 (en) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism

Also Published As

Publication number Publication date
JPWO2009072578A1 (en) 2011-04-28
JP5214632B2 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
WO2008088030A1 (en) Composition for prevention or treatment of disease associated with thrombus or embolus
WO2007090393A3 (en) Microtablet-based pharmaceutical preparation
WO2009009563A3 (en) Materials and methods for delivering compositions to selected tissues
WO2010049454A3 (en) Antimicrobial composition from copepods
EP1806134A4 (en) Agent and food for preventing/improving functional digestive disorder
WO2008013838A3 (en) Pyridizinone derivatives
EP1920774A4 (en) Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material
WO2009082152A3 (en) Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
WO2010111640A3 (en) Anti-influenza formulations and methods
MX2009012010A (en) Freeze-dried, aerated fruit or vegetable compositions and methods of making thereof.
EP2011492A4 (en) Gip secretion inhibitor
WO2009149785A8 (en) Highly active antioxidant based on trehalulose
EP2153834A3 (en) Extended release pharmaceutical compositions comprising quetiapine salts
EP2644614A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2009051223A1 (en) Pharmaceutical composition for treatment of cataract
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
WO2008155998A1 (en) Antianxiety/antidepressant agent
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2010127787A3 (en) Active ingredient combinations having insecticidal and acaricidal properties
WO2010082689A3 (en) Gip-increase inhibitor
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2007125521A3 (en) Polymorphic form of zoledronic acid and processes for their preparation
EP1944027A4 (en) Pharmaceutical composition for treatment or prevention of nephritis and method for producing same
WO2010117194A3 (en) Composition for preventing or treating gastric disorders containing an active component comprising a fatty acid series compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08858326

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009544721

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08858326

Country of ref document: EP

Kind code of ref document: A1